CompoAtlas

DermaNiA

Natural health product licensed in Canada

Licence holder
Barentz Canada ULC
NPN or DIN-HM
80115966
Status
Active licence
Licence date
30 January 2022
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Zizania latifolia

Extract : Matériel brut frais

Extraction ratio : 6.25:1

Dry plant equivalent : 781.25 mg

125 mgNot calculated

Non-medicinal ingredients

Carboxyméthylcellulose de sodium, Cellulose microcristalline, Phosphate dicalcique, Silice, Hypromellose, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps improve facial skin moisture. For healthy hydrated facial skin. Helps to improve/increase facial skin hydration. Helps to maintain facial skin hydration. Helps support facial skin hydration. Helps to retain facial skin moisture. Helps to maintain facial skin moisture. Helps reduce the number of fine lines and wrinkles. Helps reduce the number of fine facial lines.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80115966

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line